U&I Corporation - Asset Resilience Ratio
U&I Corporation (056090) has an Asset Resilience Ratio of 0.13% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how U&I Corporation's Asset Resilience Ratio has changed over time. Check 056090 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down U&I Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see U&I Corporation stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩165.86 Million | 0.13% |
| Total Liquid Assets | ₩165.86 Million | 0.13% |
Asset Resilience Insights
- Limited Liquidity: U&I Corporation maintains only 0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
U&I Corporation Industry Peers by Asset Resilience Ratio
Compare U&I Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic PLC
XETRA:2M6 |
Medical Devices | 7.91% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Aroa Biosurgery Ltd
AU:ARX |
Medical Devices | 12.13% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
MICROPORT CARDIO.MEDTECH.
F:72X |
Medical Devices | 37.03% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
Annual Asset Resilience Ratio for U&I Corporation (2015–2025)
The table below shows the annual Asset Resilience Ratio data for U&I Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.35% | ₩397.15 Million ≈ $269.15K |
₩114.92 Billion ≈ $77.88 Million |
-6.52pp |
| 2024-12-31 | 6.87% | ₩7.36 Billion ≈ $4.99 Million |
₩107.20 Billion ≈ $72.65 Million |
+4.72pp |
| 2023-12-31 | 2.15% | ₩1.70 Billion ≈ $1.15 Million |
₩79.10 Billion ≈ $53.60 Million |
-34.96pp |
| 2022-12-31 | 37.11% | ₩52.49 Billion ≈ $35.57 Million |
₩141.44 Billion ≈ $95.85 Million |
+10.22pp |
| 2021-12-31 | 26.89% | ₩20.18 Billion ≈ $13.68 Million |
₩75.06 Billion ≈ $50.87 Million |
+11.62pp |
| 2020-12-31 | 15.27% | ₩9.84 Billion ≈ $6.67 Million |
₩64.43 Billion ≈ $43.66 Million |
+6.93pp |
| 2019-12-31 | 8.34% | ₩5.93 Billion ≈ $4.02 Million |
₩71.08 Billion ≈ $48.17 Million |
-11.97pp |
| 2018-12-31 | 20.31% | ₩15.20 Billion ≈ $10.30 Million |
₩74.86 Billion ≈ $50.73 Million |
-12.11pp |
| 2017-12-31 | 32.42% | ₩25.63 Billion ≈ $17.37 Million |
₩79.08 Billion ≈ $53.59 Million |
-9.99pp |
| 2016-12-31 | 42.40% | ₩28.05 Billion ≈ $19.01 Million |
₩66.16 Billion ≈ $44.84 Million |
+3.40pp |
| 2015-12-31 | 39.01% | ₩30.20 Billion ≈ $20.47 Million |
₩77.42 Billion ≈ $52.47 Million |
-- |
About U&I Corporation
CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cerv… Read more